Abstract
European Journal of Clinical InvestigationVolume 35, Issue s1 p. 1-3 Factor Xa inhibition P. Bramlage, P. BramlageSearch for more papers by this authorD. Pittrow, Corresponding Author D. PittrowDavid Pittrow, Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Fiedlerstr. 27, 01307 Dresden, Germany. Tel.: +49 351 458 2815; fax: +49 351 458 4341; e-mail: david.pittrow@mailbox.tu-dresden.deSearch for more papers by this authorW. Kirch, W. KirchSearch for more papers by this author P. Bramlage, P. BramlageSearch for more papers by this authorD. Pittrow, Corresponding Author D. PittrowDavid Pittrow, Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Fiedlerstr. 27, 01307 Dresden, Germany. Tel.: +49 351 458 2815; fax: +49 351 458 4341; e-mail: david.pittrow@mailbox.tu-dresden.deSearch for more papers by this authorW. Kirch, W. KirchSearch for more papers by this author First published: 08 February 2005 https://doi.org/10.1111/j.0960-135X.2005.01450.x Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Germany (P. Bramlage, D. Pittrow, W. Kirch). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume35, Issues1March 2005Pages 1-3 RelatedInformation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
